Virtu Financial LLC Sells 54,214 Shares of ASP Isotopes Inc. (NASDAQ:ASPI)

Virtu Financial LLC lessened its stake in ASP Isotopes Inc. (NASDAQ:ASPI) by 82.3% during the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 11,693 shares of the company’s stock after selling 54,214 shares during the quarter. Virtu Financial LLC’s holdings in ASP Isotopes were worth $33,000 at the end of the most recent reporting period.

Several other hedge funds also recently modified their holdings of ASPI. BNP PARIBAS ASSET MANAGEMENT Holding S.A. purchased a new stake in ASP Isotopes in the 3rd quarter valued at $6,249,000. Telemark Asset Management LLC purchased a new stake in shares of ASP Isotopes in the third quarter valued at about $4,726,000. Geode Capital Management LLC lifted its position in shares of ASP Isotopes by 42.7% during the third quarter. Geode Capital Management LLC now owns 1,118,423 shares of the company’s stock valued at $3,110,000 after purchasing an additional 334,836 shares in the last quarter. Philadelphia Financial Management of San Francisco LLC boosted its holdings in ASP Isotopes by 158.3% during the third quarter. Philadelphia Financial Management of San Francisco LLC now owns 991,863 shares of the company’s stock worth $2,757,000 after purchasing an additional 607,893 shares during the last quarter. Finally, State Street Corp boosted its holdings in ASP Isotopes by 12.8% during the third quarter. State Street Corp now owns 853,695 shares of the company’s stock worth $2,373,000 after purchasing an additional 96,604 shares during the last quarter. Hedge funds and other institutional investors own 16.80% of the company’s stock.

ASP Isotopes Stock Performance

NASDAQ ASPI opened at $4.89 on Friday. The company has a market capitalization of $349.10 million, a PE ratio of -8.02 and a beta of 3.27. The company has a debt-to-equity ratio of 0.80, a quick ratio of 7.54 and a current ratio of 7.55. ASP Isotopes Inc. has a 52-week low of $1.65 and a 52-week high of $9.33. The company has a 50-day simple moving average of $5.83 and a 200 day simple moving average of $3.91.

Analysts Set New Price Targets

Several equities analysts have commented on the stock. Canaccord Genuity Group reissued a “buy” rating and set a $4.50 target price on shares of ASP Isotopes in a research report on Friday, October 18th. Canaccord Genuity Group started coverage on ASP Isotopes in a report on Friday, October 4th. They set a “buy” rating and a $4.50 price target on the stock.

ASP Isotopes Profile

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.